In a recent Louisiana case, the court considered whether a health information technology (HIT) company should be held liable for failing to detect prescriber errors in the prescriptions that the company transmits to pharmacies.

David B. Brushwood, BSPharm, JD

Nationwide, a little over a third of the patients who would benefit from statin medication are taking them, according to a study published in the Annals of Internal Medicine.

Elizabeth Briand

Health-conscious consumers seeking convenient methods to optimize nutrition for wellness and health promotion and patients with conditions affecting their ability to obtain adequate nutrients may seek convenient supplements.

The American Diabetes Association (ADA) released its latest round of updates to their standards of care in diabetes for 2024 at the end of 2023.

Olivia C. Welter, PharmD

Updates from FDA

Androgenetic alopecia (AGA), also known as male pattern baldness or female pattern hair loss, affects up to 80% of men and 50% of women over their lifetime, with white men and women more likely to experience hair loss than other ethnicities.

Mary Warner

Collagen is a leader in the supplements market, advertised as a boon to joint and bone health, and a remedy for aspects of aging such as dehydration, loss of skin elasticity, and wrinkles.

Mickie Cathers

Semaglutide, a GLP-1 receptor agonist, has lowered the risk of CV events for untold patients with T2D. But does the drug offer the same protective effects to the growing number of people without diabetes who now take the drug for weight loss? New research says “yes.”

Sonya Collin

Over half of survey participants were open to using pharmacies for testing and treatment of influenza and group A streptococcal pharyngitis infections, according to study results published in the January/February 2023 issue of JAPhA. They were also willing to pay $25 or more for out-of-pocket testing costs.

Clarissa Chan, PharmD

More than 42% of Americans have obesity. Given that obesity raises risk for numerous chronic illnesses and cancers, this subset of the population likely receives a substantial proportion of the medications prescribed in the United States. But they might not be getting the right dose.

Sonya Collins

Trending Topics

The utility of cystatin C—a protein biomarker similar to creatinine—has often been overlooked in routine practice as an alternative measurement of estimated glomerular filtration rate (eGFR) in patients with kidney disease.

Corey Diamond, PharmD

Pulse oximeters send beams of light through the skin to measure the amount of oxygen in the blood. Health care providers who rely on the technology have long known that the tool can yield inaccurate readings for people with darker skin.

Sonya Collins

The use of direct oral anticoagulants for stroke prevention in patients with AFib can cause a risk of bleeding and therefore limits their use. A recent study from the OCEANIC–AF Steering Committee investigated the efficacy of asundexian, an activated factor XI inhibitor that may prevent strokes with less bleeding. In the phase 3, international, double-blind trial, published in the January 2, 2025, issue of NEJM, almost 15,000 high-risk patients with AFib in 38 countries were assigned in a 1:1 ratio to receive asundexian at a dose of 50 mg once daily or standard-dose apixaban.

Gluten-related disorders, including but not limited to celiac disease, non-celiac gluten sensitivity (NCGS), and wheat allergy, affect millions of people worldwide with an estimated global prevalence of about 5%.

Jamie Huff, PharmD

APhA Member News

Crossword Challenge